Telehealth Delivery of Adherence and Medication Management System Improves Outcomes in Inner-City Children With Asthma

PEDIATRICS ◽  
2020 ◽  
Vol 146 (Supplement 4) ◽  
pp. S368-S369
Author(s):  
Deepti R. Deshpande ◽  
Joyce E. Yu
2020 ◽  
Vol 55 (4) ◽  
pp. 858-865 ◽  
Author(s):  
Nancy Y. Lin ◽  
Rachelle R. Ramsey ◽  
James L. Miller ◽  
Karen M. McDowell ◽  
Nanhua Zhang ◽  
...  

2019 ◽  
Vol 49 (4) ◽  
pp. 317-323
Author(s):  
Melissa T. Baysari ◽  
Rae‐Anne Hardie ◽  
Peter Barclay ◽  
Johanna I. Westbrook

2008 ◽  
Vol 8 (5) ◽  
pp. 288-293 ◽  
Author(s):  
Maria Fagnano ◽  
Kelly M. Conn ◽  
Jill S. Halterman

PEDIATRICS ◽  
1995 ◽  
Vol 96 (2) ◽  
pp. 388-389
Author(s):  
Clifton T. Furukawa ◽  
Kirk A. Kinberg

The prevalence of asthma among innercity children may be substantially higher than has been appreciated. This may imply that in this population a large number of children with asthma may be inadequately diagnosed and treated.


2021 ◽  
Vol 42 (4) ◽  
pp. 310-316
Author(s):  
Kenny Y. Kwong ◽  
Yang Z. Lu ◽  
Emilio Jauregui ◽  
Lyne Scott

Background: Airway remodeling has been shown to be persistent in patients with asthma despite treatment with controller medications. Patients with early airflow obstruction may continue to experience poor lung function despite treatment. Objectives: To determine whether early airflow obstruction in inner-city children with asthma persists despite guideline-based asthma care. Methods: In a retrospective study that used a cohort of inner-city children with asthma treated by using an asthma-specific disease management system, the patients were stratified into “low” or “high” lung function groups at the time of the initial visit (high, forced expiratory volume in the first second of expiration [FEV1] % predicted and FEV1/forced vital capacity [FVC] ≥ 80%; and low, FEV1% predicted and FEV1/FVC < 80%). These patients then received National Heart, Lung, and Blood Institute guideline‐based asthma treatment at regular follow-up intervals with spirometry performed at these visits as part of regular care. FEV1% predicted and FEV1/FVC were followed up for up to 10 years for both the high and low cohorts. Results: Over 10 years, the patients initially in the “high” group maintained FEV1% predicted and FEV1/FVC at values similar to the initial visit (94 to 96% and 87 to 89%, respectively), whereas those in the low group had only slight increases of FEV1% predicted and FEV1/FVC over the same time (77 to 82% and 78 to 82%, respectively). Low FEV1% predicted and FEV1/FVC at the time of the first visit was significantly associated with an increased risk of low values of these lung functions over the next 3‐5 years despite treatment. African American ethnicity and male gender were also associated with lower lung function over time. Conclusion: Early airflow obstruction in inner city children asthma is associated with poor lung function in later life despite guideline-based asthma care. Current asthma therapy may not affect pathways and leads to airway remodeling in children with asthma.


PEDIATRICS ◽  
1999 ◽  
Vol 104 (Supplement_2) ◽  
pp. 375-375
Author(s):  
James E. Gern

Author(s):  
Samhith Kethireddy Abigail Swamidoss ◽  
Bushra Alghamdi ◽  
Ronald L. Hickman ◽  
Shanina Knighton ◽  
Miriam Pekarek ◽  
...  

Abstract Independent living care for polypharmacy patients can be complicated in those situations with medications that are pro re nata (PRN, “as needed”). Such medication regimen may involve multiple dosing whereby specific drug contraindications might be easily overlooked by hospice and palliative care patients, or by those isolated and not in regular contact with care providers. The goal of this paper is to describe the development steps and current design of a system providing medication decision support for isolated patients. With an increased number of patients living alone or isolated - a situation exacerbated during the COVID19 pandemic – polypharmacy patients may be challenged when PRN (as needed) medications confound what might ordinarily be a routine medication schedule. Central to our medication management system design is the so-called “conversational agent” that when integrated with a natural language processing front- end and classification tree algorithm provide a dynamic framework for patient self-management of medications. Research on “patient need” revealed patients were more likely to embrace the system if the system were autonomous, secure, and not cloud-based.


2012 ◽  
Vol 42 (4) ◽  
pp. 264-267 ◽  
Author(s):  
Eyra E Munzner ◽  
Susan A Welch ◽  
Katrina L Richardson

2007 ◽  
Vol 85 (1) ◽  
pp. 52-61 ◽  
Author(s):  
Jill Berg ◽  
Rob McConnell ◽  
Joel Milam ◽  
Judith Galvan ◽  
Jenny Kotlerman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document